Articles

  • Jan 15, 2025 | blog.tipranks.com | Jeff Fischer

    The Hershey Company ($HSY), a stock many people wish they had in their portfolio, has finally given new investors a chance to own it. More than just a dip, HSY stock is lower by about 23% over the past four months, and 43% over the last 20 months. With chocolate industry leaders Ferrero Rocher and Mars Wrigley inaccessible to retail investors (they’re both privately owned), Hershey is the only ticket in town, and I do believe it’s a worthwhile investment at this point.

  • Jan 13, 2025 | tipranks.com | Jeff Fischer

    It might surprise some investors that the price of gold has meaningfully outperformed the stock prices of companies that mine gold as their primary business. Logically, one would expect that the cost structure of those companies would make their operations highly leveraged to any rise in the price of gold.

  • Dec 9, 2024 | tipranks.com | Jeff Fischer

    Shares of clothing retailer the GAP (GAP) have perked up recently, but generally remain rangebound. I believe there’s an image problem here as many investors view the company as stale. Nonetheless, Gap delivers consistent results, has seen margin gains, and is participating in exciting new fashion trends. For these reasons, I rate GAP stock a Buy.

  • Dec 5, 2024 | tipranks.com | Jeff Fischer

    The Toronto-Dominion Bank (TD) (TSE:TD), Canada’s second-largest financial institution with a sizable retail banking operation in the United States, has had a rough year. From a business perspective, the company recently settled an anti-money laundering (AML) violation with the U.S. Department of Justice (DOJ) and has posted poor results. For investors, TD is the only major Canadian bank whose stock has experienced losses this year, and it’s not insignificant.

  • Nov 8, 2024 | contagionlive.com | Sophia Abene |Jeff Fischer

    Longhorn Vaccines and Diagnostics has developed a promising new sepsis vaccine utilizing a composite peptide approach that targets three major toxins: lipopolysaccharide (LPS), lipoteichoic acid (LTA), and peptidoglycan. Designed to prevent sepsis and improve the effectiveness of existing antibiotics, this vaccine may also hold potential for treating a range of inflammatory diseases such as Alzheimer's, Parkinson's, heart disease, and cancer.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →